John J. Alam, SVP, Drug Eval. & Appr at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,500 shares at $37.78 ($57K) on 2006-12-20, disclosed to the SEC on 2006-12-21.
Scheduled sale ($57k) by SVP, Drug Eval. & Appr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.78 | 500 | $19K | 33.3% |
| 2 | $37.78 | 1,000 | $38K | 66.7% |
| Total | $37.78 avg | 1,500 | $57K | 100% |
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |